IP Library Granted Patent US 7,262,013
Granted Patent B2
US 7,262,013 · App. 10/926,534 · Granted Aug 28, 2007

Bisulfite method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,262,013
App. No.
10/926,534
Granted
Aug 28, 2007
Kind
B2
Abstract

The invention provides methods for purifying bisulfite-treated nucleic acid samples.

Claims (22)

1. A method for the purification of a bisulfite-treated nucleic acid comprising the steps of:

(a) providing a liquid comprising a bisulfite-treated nucleic acid in a size-exclusion device comprising a porous, size-discriminating barrier;

(b) washing said nucleic acid in said size-exclusion device by passing liquid through said barrier while said imcleic acid is retained by said barrier;

(c) treating said washed nucleic acid with a base in said size-exclusion device to increase the pH; and

(d) optionally washing said nucleic acid resulting from step (c), resulting in a purified bisulfite-treated nucleic acid.

2. The method of claim 1 wherein said step (d) is performed in said size-exclusion device.

3. The method of claim 1 wherein said porous, size-discriminating barrier has a 300K cut off.

4. The method of claim 1 wherein said porous, size-discriminating barrier has a 30K cut off.

5. The method of claim 1 wherein said porous, size-discriminating barrier has a 100K cut off.

6. A method of converting one or more cytosine bases to uracil bases in a nucleic acid, the method comprising:

contacting the nucleic acid with a bisulfite conversion reagent, thereby forming a bisulfite-treated nucleic acid,

washing the treated nucleic acid in a size-exclusion device comprising a porous, size-discriminating barrier that allows residual bisulfite conversion reagent to pass through while retaining the bisulfitetreated nucleic acid, and

subjecting the retained bisulfite-treated nucleic acid to basic conditions comprising a pH of 10 or above, during or after said washing, to form a nucleic acid in which at least one cytosine base has been converted to a uracil base.

7. The method of claim 6 wherein the porous, size-discrimination barrier comprises a membrane.

8. The method of claim 6 wherein said barrier has a 300K cut off.

9. The method of claim 6 wherein said barrier has a 100K cut off.

10. The method of claim 6 wherein said barrier has a 30K cut off.

11. The method of claim 6 wherein said washing is performed under pressure.

12. The method of claim 6 wherein said washing comprises centrifugation of the device.

13. The method of claim 6 wherein said bisulfite conversion reagent comprises sodium bisulfite.

14. The method of claim 6 wherein said bisulfite conversion reagent comprises magnesium bisulfite.

15. The method of claim 6 wherein said basic conditions comprise 0.1M NaOH.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038002/0697 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2004
From: BOYD, VICTORIA L.; ZON, GERALD
To: APPLERA CORPORATION
Reel/Frame 015474/0594 →